Brief: Mink Therapeutics - Ended Q3 With Cash Balance Of $6.4 Million
09/11/2023 12:35
Nov 9 (Reuters) - Mink Therapeutics Inc INKT.O :
* MINK THERAPEUTICS REPORTS THIRD QUARTER 2023 RESULTS
* ENDED Q3 WITH A CASH BALANCE OF $6.4 MILLION
* QTRLY LOSS PER SHARE $0.15
* Q3 EARNINGS PER SHARE VIEW $-0.18 -- LSEG IBES DATA
Source text for Eikon: ID:nGNX8rCpS
Further company coverage: INKT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mink Therapeutics
See all newsMiNK Therapeutics Q2 loss narrows on expense discipline
Brief: MiNK Therapeutics Q2 EPS USD -0.62
Mink Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Brief: MiNK Therapeutics Says No Major Serious Adverse Events Attributed To Agent-797 In First Patients
U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's